International Journal of Gynecology & Obstetrics
Volume 83, Issue 3 , Pages 251-255, December 2003

Cervical ripening with oral misoprostol at term

Department of Obstetrics & Gynecology, Arash Maternity Hospital, Tehran University of Medical Sciences, Tehran, Iran

Received 18 February 2003; received in revised form 29 May 2003; accepted 4 June 2003.

Abstract 

Objectives: To determine the efficacy of 200 μg single dose oral misoprostol as a cervical priming agent at term. Methods: In this double-blind randomized trial, 156 pregnant women requiring induction of labor with gestational age of 37–42 weeks and Bishop score ≤5, were randomized to receive either 200 μg of misoprostol or a placebo, orally. Labor was induced with intravenous oxytocin infusion 12 h after oral medication if the patient did not go into labor. The primary outcome was the change in the Bishop score 12 h after oral medication. The secondary outcomes were the timings starting from the drug administration to the onset of uterine activity, interval between oral medication and delivery, oxytocin need for induction, mode of delivery, frequency of side effects, and neonatal and maternal outcome. The chi-square or Fisher exact test, Student's t-test, and Mann–Whitney U-test were used for analysis of the data. Results: There were no significant differences in maternal characteristics or indications of induction. The Bishop score 12 h after oral medication significantly improved in the misoprostol group compared with the control group [55 (70%)>8 vs. 4 (5%)>8; P<0.001]. The induction rate was significantly reduced in the misoprostol group (P<0.001). The interval between oral medication and the onset of uterine activity was significantly shorter in the misoprostol group (P<0.001). The interval between oral medication and delivery was also significantly shorter in the misoprostol group (P<0.001). The cesarean delivery rate was significantly lower in the misoprostol group (P<0.001). There were no differences between the groups with respect to the incidence of tachysystole, hyperstimulation, adverse neonatal or maternal outcome. Conclusions: Oral administration of 200 μg single dose of misoprostol is an effective agent not only for cervical priming but also for induction of labor at term. Furthermore, it reduces the rate of cesarean deliveries.

Keywords: Misoprostol, Cervical ripening, Induction of labor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0020-7292(03)00275-3

doi:10.1016/S0020-7292(03)00275-3

International Journal of Gynecology & Obstetrics
Volume 83, Issue 3 , Pages 251-255, December 2003